I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 4 studies | 23% ± 3% | |
| myeloid cell | 3 studies | 23% ± 4% | |
| epithelial cell | 3 studies | 30% ± 7% | |
| ciliated cell | 3 studies | 17% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 4 studies | 23% ± 3% | |
| myeloid cell | 3 studies | 23% ± 4% | |
| epithelial cell | 3 studies | 30% ± 7% | |
| ciliated cell | 3 studies | 17% ± 0% |
Insufficient scRNA-seq data for expression of SLC35F6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 3440.66 | 459 / 459 | 100% | 86.92 | 1118 / 1118 |
| esophagus | 100% | 2899.16 | 1445 / 1445 | 100% | 66.40 | 183 / 183 |
| kidney | 100% | 3546.48 | 89 / 89 | 100% | 93.38 | 901 / 901 |
| ovary | 100% | 1702.24 | 180 / 180 | 100% | 44.02 | 430 / 430 |
| prostate | 100% | 2606.72 | 245 / 245 | 100% | 68.99 | 502 / 502 |
| lung | 100% | 2676.09 | 577 / 578 | 100% | 55.88 | 1155 / 1155 |
| skin | 100% | 3884.46 | 1809 / 1809 | 100% | 85.18 | 471 / 472 |
| uterus | 100% | 2375.27 | 170 / 170 | 100% | 57.87 | 458 / 459 |
| liver | 100% | 2021.63 | 226 / 226 | 100% | 55.02 | 405 / 406 |
| stomach | 100% | 1672.35 | 358 / 359 | 100% | 54.02 | 286 / 286 |
| intestine | 100% | 2005.79 | 966 / 966 | 100% | 49.25 | 525 / 527 |
| bladder | 100% | 2470.86 | 21 / 21 | 99% | 52.41 | 501 / 504 |
| brain | 99% | 1553.82 | 2624 / 2642 | 100% | 51.09 | 705 / 705 |
| adrenal gland | 100% | 4032.75 | 258 / 258 | 99% | 47.42 | 227 / 230 |
| thymus | 100% | 3052.17 | 653 / 653 | 99% | 58.91 | 597 / 605 |
| pancreas | 98% | 1161.79 | 321 / 328 | 99% | 46.80 | 177 / 178 |
| adipose | 100% | 3687.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 54.40 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 31.34 | 29 / 29 |
| spleen | 100% | 2328.70 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 52.14 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 25.23 | 1 / 1 |
| blood vessel | 100% | 1941.75 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1638.41 | 851 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 1599.81 | 784 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 91% | 1145.77 | 850 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_1901029 | Biological process | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| GO_0022857 | Molecular function | transmembrane transporter activity |
| Gene name | SLC35F6 |
| Protein name | Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog) Solute carrier family 35 member F6 |
| Synonyms | UNQ3047/PRO9863 C2orf18 |
| Description | FUNCTION: Involved in the maintenance of mitochondrial membrane potential in pancreatic ductal adenocarcinoma (PDAC) cells. Promotes pancreatic ductal adenocarcinoma (PDAC) cell growth. May play a role as a nucleotide-sugar transporter. . |
| Accessions | Q8N357 ENST00000344420.10 ENST00000414029.1 F8WCT7 ENST00000429494.5 F8WB19 |
